Bifidobacterium infantis
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Bifidobacterium infantis, covering 2012-02-13 to 2024-12-13. Get the full timeline:
Most recent: Clinical Trial Update: Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity [NA]